MedTrace Logo

Effects of Heparin on Arteriovenous Fistula Patency

NCT02493504 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2015-07-09

No results posted yet for this study

Summary

Arteriovenous fistula (AVF) is now the optimal method of obtaining vascular access for dialysis. Measures such as systemic anticoagulation have been proposed as means of increasing patency rates but enough evidence does not exist to support their use. The investigators aimed to evaluate the efficacy of preoperative heparin injection on patency of AVF during the first 24 hours after surgery and to determine whether such measure can be used to prevent early thrombosis of the vascular access.

Conditions

  • Arteriovenous Fistula

Interventions

DRUG

Heparin

100units/kg of heparin were administered for the case group after dissection prior to anastomosis.

Sponsors & Collaborators

  • Fatemeh Hoseinzadegan

    lead OTHER

Principal Investigators

  • Mohammad Mozafar, M.D. · Associate Professor of General and Vascular Surgery

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2012-04-30
Completion
2013-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02493504 on ClinicalTrials.gov